TELA Bio (TELA) Capital Expenditures Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | 1.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15% |
| Dec 31, 2025 | -20.57% |
| Sep 30, 2025 | 1.72% |
| Jun 30, 2025 | 37.51% |
| Mar 31, 2025 | -54.33% |
| Dec 31, 2024 | -20.73% |
| Sep 30, 2024 | 137.52% |
| Jun 30, 2024 | -89.82% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | 53.64% |
| Sep 30, 2023 | 121.17% |
| Jun 30, 2023 | -63.33% |
| Mar 31, 2023 | 19.14% |
| Dec 31, 2022 | 196.94% |
| Sep 30, 2022 | -56.59% |
| Jun 30, 2022 | -87.90% |
| Mar 31, 2022 | 91.29% |
| Dec 31, 2021 | 198.14% |